Prognosis and prognostic factors of patients with papillary carcinoma showing distant metastasis at surgery (M1 patients) in Japan

Endocrine Journal

Volumn 57, Issue 6, 2010, Pages 523-531

  Ito, Yasuhiro ^a   Masuoka, Hiroo ^a   Fukushima, Mitsuhiro ^a   Inoue, Hiroyuki ^a   Kihara, Minoru ^a   Tomoda, Chisato ^a   Higashiyama, Takuya ^a   Takamura, Yuuki ^a   Kobayashi, Kaoru ^a   Miya, Akihiro ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Distant metastasis; Papillary carcinoma; Prognostic factor; Thyroid

Indexed keywords

THYROTROPIN; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CHILD; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HORMONE INHIBITION; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PREOPERATIVE EVALUATION; PROGNOSIS; RADIOISOTOPE THERAPY; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL RATE; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME; ANTAGONISTS AND INHIBITORS; BONE TUMOR; BRAIN TUMOR; CARCINOMA, PAPILLARY; JAPAN; LUNG TUMOR; LYMPH NODE DISSECTION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; SECONDARY; THYROID NEOPLASMS; THYROIDECTOMY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; JAPAN; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN;

EID: 77954751619     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-019     Document Type: Article

References (19)

1. Cady B, Rosai R. (1988) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
2. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. (2004) A novel classification system for patients with PTC: addition of the new variable of large (3 cm or greater) nodal metastases and reclassiication during the followup period. Surgery 135: 139-148.
3. Dinneen SF, Valimaki MJ, Bergstralh EJ, Boellner JR, Gorman CA, Hay ID. (1995) Distant metastasis in apillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80: 2041-2045.
4. Schlumberger M, Tubiana M, de Vathaire F, Hill C, Gardet P, Travagli JP, Fragu P, Lumbroso J, Caillou B, Parmentier C. (1986) Long-term results of treatment of 283 patients with lung and bone metastasis from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63: 960-967.
5. Pacini F, Cetani F, Micolli P, Mancusi F, Ceccarelli C, Lippi F, Marino E, Pinchera A. (1994) Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18: 600-604.
6. Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, Shah JP, Shaha AR. (2003) Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am College Surg 197: 191-197.
7. Haq M, Harmer C. (2005) Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol 63: 87-93.
8. Sugitani I, Fujimoto Y, Yamamoto N. (2008) Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143: 35-42.
9. Sobin LH, Wittekind Ch.eds. (2002) UICC: TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss.
10. Sakamoto A, Kasai N, Sugano H. (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52: 1849-1855.
11. Ito Y, Miyauchi A. (2009) Prognostic factors and therapetutic strategies for differentiated carcinoma of the thyroid. Endocr J 56: 177-192.
12. Sugino K, Kure Y, Ozaki O, Ito K. (1993) Surgical treatment of locally advanced thyroid cancer. Surg Today 23: 791-794.
13. Kowlaski LP, Filho JG. Results of the treatment of locally invasive thyroid carcinoma. (2002) Head Neck 24: 340-344.
14. Tanaka K, Sonoo H, Yamamoto Y, Udagawa K, Arime I, Kunisue H, Yamamoto S, Kurebayashi J, Shimozuma K. (1999) Analyses of the outcome of locally invasive papillary thyroid carcinoma. Thyroid 9: 1017-1022.
15. Durante C, Haddy N, Baudin E, Leboulleux S, Harti D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schulumberger M. (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91: 2892-2899.
16. Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L. (1997) Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl med 38: 669-675.
17. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C. (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37: 598-605.
18. Biondi B, Filetti S, Schlumberger M. (2005) Thyroidhormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1: 32-40.
19. McGriff NJ, Csako G, Gourgiotis L, Lori CG, Pucino F, Sasrlis NJ. (2002) Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34: 554-564.